Viz.ai policy evolution
Before/after stance changes across captured policy versions, with exact citations. If no before/after delta is available yet, AIRIN shows the latest citation-backed stance events instead.
No before/after stance delta is available for this filter yet. Latest citation-backed stance events are shown below.
Aug 14, 2026trainingmedium
content license
Latest stance: broad license
“Data. Viz is continually improving, adjusting, and testing the App and Services. You grant Viz a non-exclusive license to use, reproduce, distribute, display and modify data you enter into the App or the Services (“Data”) in order to (i) to deliver the App and Services to you and (ii) to de-identify any protected health information as defined in the Health Insurance Portability and Accountability Act of 1996 (“ PHI ”) contained in the Data in accordance with 45 C.F.R. § 164.514(b) (“De-Identified Data”) and use such De-Identified Data to support the delivery of the App and Services, and for product modification, adjustment, testing and improvement, development of new products and services, research, and to support regulatory filings, including FDA submissions, and for any other lawful purpose.”
Open citationAug 14, 2026trainingmedium
content license
Latest stance: broad license
“Data. Viz is continually improving, adjusting, and testing the App and Services. You grant Viz a non-exclusive license to use, reproduce, distribute, display and modify data you enter into the App or the Services (“Data”) in order to (i) to deliver the App and Services to you and (ii) to de-identify any protected health information ( as defined in the Health Insurance Portability and Accountability Act of 1996 (“ PHI ”)) contained in the Data in accordance with 45 C.F.R. § 164.514(b) (“De-Identified Data”) and use such De-Identified Data to support the delivery of the App and Services, and for product modification, adjustment, testing and improvement, development of new products and services, research, and to support regulatory filings, including FDA submissions, and for any other lawful purpose.”
Open citationJun 17, 2026trainingmedium
content license
Latest stance: broad license
“License. Subject to this EULA, we grant you a non-exclusive, non-transferrable license to use the App to access and use the Services. You represent and warrant that you will only use the App and Services if you are a medical specialist with the requisite clinical expertise to use the App and Services. If Viz has provided the App and Services for training or demonstration purposes only, you represent and warrant that you will not use the App or Services for any clinical, diagnostic, or patient care-related activities.”
Open citationJun 17, 2026traininglow
model training
Latest stance: no training claim
“License. Subject to this EULA, we grant you a non-exclusive, non-transferrable license to use the App to access and use the Services. You represent and warrant that you will only use the App and Services if you are a medical specialist with the requisite clinical expertise to use the App and Services. If Viz has provided the App and Services for training or demonstration purposes only, you represent and warrant that you will not use the App or Services for any clinical, diagnostic, or patient care-related activities.”
Open citationGenerated from live stance events. Informational only, not legal advice.